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Summary 
The nuclear cap-binding complex (CBC) stimulates processing reactions of 
capped RNAs, including their splicing, 3'end formation, degradation and 
transport. CBC effects are particular for individual RNA families, but how such 
selectivity is achieved remains elusive. Here, we analyze three main CBC 
partners known to impact different RNA species. ARS2 stimulates 3'end-
formation/transcription termination of several transcript types; ZC3H18 
stimulates degradation of a diverse set of RNAs and PHAX functions in pre-
sn(o)RNA transport. Surprisingly, these proteins all bind capped RNAs without 
strong preferences for given transcripts and their steady-state binding 
correlates poorly with their function. Despite this, PHAX and ZC3H18 compete 
for CBC-binding and we demonstrate that this competitive binding is 
functionally relevant. We further show that CBC-containing complexes are 
short-lived in vivo, and therefore suggest that RNA fate involves the transient 
formation of mutually exclusive CBC complexes, which may only be 
consequential at particular check-points during RNA biogenesis.  
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Introduction 
All RNA polymerase II (RNAPII) transcripts undergo processing events that are 
essential for their function. Early during RNA synthesis, an m7-G cap is added to the 
nascent  5’end  by an enzymatic complex that binds the Serine 5 phosphorylated form 
of the C-terminal domain (CTD) of RNAPII (Bentley, 2014). By protecting the nascent 
RNA  from  5’ to 3’  degradation,  the cap thus represents the hallmark of a successfully 
initiated RNAPII transcript (Furuichi et al., 1977). Importantly, the cap also serves a 
key role in many aspects of nuclear RNA biology (Gonatopoulos-Pournatzis and 
Cowling, 2014). Nuclear cap functions are mediated by the CBP80 and CBP20 
proteins (also named NCBP1 and NCBP2), composing the nuclear cap-binding-
complex (CBC) that associates co-transcriptionally with the nascent RNA (Glover-
Cutter et al., 2008; Görnemann et al., 2005; Narita et al., 2007). CBP20 interacts 
directly with the m7-G cap through its classical RNA Recognition Motif (RRM), while 
CBP80 ensures high affinity binding of the full CBC and provides a platform for 
interactions with other factors (Calero et al., 2002; Izaurralde et al., 1994; Mazza et 
al., 2001; Mazza et al., 2002). 
The CBC is highly specific for guanosine caps modified at position N7 (m7G 
cap). Cap-adjacent nucleotides may also carry modifications, but it is believed that 
these nucleotides increase CBC affinity in a rather non-sequence specific manner 
(Worch et al.). In   the   following,   we   therefore   refer   to   ‘capped   RNA’   as   transcripts  
carrying an m7G cap, regardless of the identity or modification of the adjacent 
nucleotides. The CBC is believed to bind all classes of m7-G-capped RNAs, 
including precursors and mature forms of mRNAs, stable long non-coding (lnc) 
RNAs, non-adenylated histone RNAs and precursors of spliceosomal small nuclear 
RNAs (snRNAs). It also associates with m7-G capped forms of small nucleolar RNAs 
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(snoRNAs) and labile lncRNAs, such as promoter upstream transcripts (PROMPTs) 
(Preker et al., 2011; Preker et al., 2008). Through its cap-association, the CBC 
affects nuclear RNA metabolism in ways that appear specific for different RNA 
families. In the case of conventional mRNAs, the CBC stimulates the splicing of cap-
proximal introns, the processing of RNA 3′ends and the formation of export-
competent RNPs (Cheng et al., 2006; Flaherty et al., 1997; Izaurralde et al., 1994; 
Laubinger et al., 2008). Stimulation of RNA splicing and export has been proposed to 
involve intercations of the CBC with the U4/U6.U5 tri-snRNP and ALYREF, 
respectively (Cheng et al., 2006; Pabis et al., 2013). In the case of non-adenylated 
histone mRNAs, the CBC promotes their 3'end formation in a process involving 
interactions with the ARS2, NELF-E and SLBP proteins (Gruber et al., 2012; Hallais 
et al., 2013; Narita et al., 2007). In the case of PROMPTs and other short-lived 
transcripts, such as products of readthrough transcription, the CBC recruits ARS2, 
ZC3H18 and the nuclear exosome targeting (NEXT) complex, composed of RBM7, 
ZCCHC8 and hMTR4. This leads to the formation of the CBC-NEXT (CBCN) 
complex (Fig. 1A), which promotes RNA degradation via the nuclear RNA exosome 
(Andersen et al., 2013; Lubas et al., 2015). Finally, in the case of snRNAs, the CBC 
promotes transcription termination, aided by ARS2, and nuclear export of the 
resulting precursors (Andersen et al., 2013; Hallais et al., 2013; Ohno et al., 2000; 
Segref et al., 2001). The latter activity involves the so-called CBC-ARS2-PHAX 
(CBCAP) complex (Hallais et al., 2013) Fig. 1A), where PHAX acts as an adaptor 
between the CBC/RNP complex and the nuclear export receptor CRM1 (Ohno et al., 
2000). PHAX and the CBC are also involved in the biogenesis of capped snoRNAs, 
directing the intranuclear transport of nascent snoRNAs to Cajal bodies (Boulon et 
al., 2004).  
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Such a broad collection of CBC functions raises the question of how specificity 
is achieved; i.e. how are different RNA families identified and brought to their proper 
processing machineries? This question is particularly relevant given the dual RNA-
productive and -degradative effects imposed by the CBC on nuclear RNA (Andersen 
et al., 2013; Hallais et al., 2013). At least part of the answer lies in the different 
protein partners of the CBC complex (Müller-McNicoll and Neugebauer 2014). As 
mentioned above, distinct CBC effectors drive different processing reactions, and 
their recognition of particular RNA families, or even individual transcripts, could 
potentially provide specificity. This concept is supported by studies of snRNAs and 
mRNAs in Xenopus oocytes, which indicate that the protein composition of the 
corresponding capped RNPs is determined by the RNA length and intronic content 
(Masuyama et al., 2004; Ohno et al., 2002). On the one hand, introns lead to the 
deposition of the exon junction complex (EJC) onto spliced RNAs (Ideue et al., 2007; 
Le Hir et al., 2000a), and the EJC communicates with the CBC to recruit the mRNA 
export adaptor ALY/REF (Cheng et al., 2006). On the other hand, RNA length 
appears to determine whether PHAX efficiently associates with CBC-bound RNAs or 
not (Masuyama et al., 2004; Ohno et al., 2002). Indeed, PHAX was suggested to 
specifically associate with short RNAs due to its active exclusion by hnRNPC 
tetramers, which bind selectively to RNAs longer than 200 nucleotides (McCloskey et 
al., 2012). Whether this mechanism applies to all nuclear RNAs is currently unknown. 
How other CBC-effectors discriminate their transcript targets and how effector-target 
recognition translates into biological activity are also unanswered questions. 
In this study, we employ transcriptome-wide in vivo RNA cross-linking 
methodology, protein-protein interaction assays, factor depletions followed by 
substrate analysis and fluorescence microscopy to functionally characterize three key 
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CBC partners, ARS2, PHAX and ZC3H18. Surprisingly, we find that the target 
specificities of these factors at steady-state are rather broad and therefore unable to 
explain the RNA family-specific activities of the CBC. In contrast, our data suggest a 
model where short-lived, mutually exclusive CBC-containing complexes determine 
RNA fate by reacting to molecular cues imposed at specific time-points during RNA 
biogenesis. 
 
Results 
ARS2, PHAX and ZC3H18 bind mRNA/pre-mRNA in a cap-proximal fashion 
To characterize how CBC-interacting factors with different biological activities might 
achieve RNA family-specific effects, we first performed individual-nucleotide 
resolution UV cross-linking and immunoprecipitation (iCLIP) with ARS2, PHAX and 
ZC3H18. These proteins all bind RNA and associate with the CBC, but with distinct 
outcomes, providing good models to test whether substrate selectivity is 
accomplished by the specific recognition of RNA by CBC partners. As comparisons, 
we conducted iCLIP with CBP20, providing a useful baseline on which to compare 
CBC partners, and included our previous iCLIP analysis of the NEXT component 
RBM7 (Lubas et al., 2015).  
For all proteins except ZC3H18, iCLIP was performed using HeLa Kyoto cell 
lines expressing, under the control of the respective endogenous gene promoters, 
‘Localization  and  Affinity  Purification’  (LAP)-tagged proteins with an N- or C-terminal 
GFP moiety ((Poser et al., 2008); Fig. S1A). Since a tagged ZC3H18 HeLa Kyoto cell 
line could not be obtained, we instead employed a C-terminally 3×FLAG-tagged 
ZC3H18 cDNA, which was introduced in a single copy into HEK293 Flp-In TREx cells 
(Andersen et al., 2013). All interrogated factors could be efficiently cross-linked to 
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RNA in a UV-dependent manner and extensive RNase I treatment of immuno-
preciptated (IP'ed) material confirmed that the majority of RNA was attached to the 
relevant proteins (Fig. S1B). The ’no-tag’ control cell lines yielded no detectable PCR 
products (Fig. S1C), implying a low experimental background. Each IP iCLIP library 
was produced in duplicate (Table S1) and the distribution of total mapped reads was 
calculated (Table S2). The replicates were generally similar to each other and 
different from both cytoplasmic poly(A)+ RNAs and rRNA-depleted total RNAs, 
revealing both reproducibility and specificity (Fig 1B, Fig. S1D and Table S2). 
As expected from their CBC-connections (Andersen et al., 2013; Hallais et al., 
2013), ARS2, PHAX, ZC3H18 and RBM7 mainly bound to capped RNAs (Fig. 1B). 
CBP20  was  highly   enriched  on   ‘mRNA  1st exons’ (Table S2), in line with its direct 
binding to the cap. ARS2 and PHAX were both enriched on snRNAs and capped 
snoRNAs, consistent with their functions in snRNA biogenesis. However, all 
interrogated factors bound mRNA as their primary transcript biotype. For PHAX this 
was somewhat unexpected, given its reported absence from long capped transcripts 
in Xenopus oocytes (Masuyama et al., 2004; Ohno et al., 2002). Selected iCLIP 
substrates were however validated by regular IPs followed by RNase protection or 
RT-qPCR analyses (Fig. S2A, S2B, S2C), as well as by manual CLIP experiments 
(Fig. S2D). 
Visual examination of representative examples of canonical pre-mRNAs 
demonstrated that CBP20, ARS2, PHAX and ZC3H18 exhibited a cap-proximal 
cross-linking preference (Fig. 1C and 1D). Although such tendency was also reported 
for RBM7 (Lubas et al., 2015), this protein associated relatively more with the bodies 
of the examined transcripts. To more generally assess factor binding, we employed a 
set of 5,769 well-annotated pre-mRNAs, containing no other annotated transcription 
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start sites (TSSs) or transcript termination sites (TTSs) in the interrogated regions, 
and calculated the fraction of iCLIP reads falling within the first 100, 500 or 1000 cap-
proximal nucleotides. As expected, the CBP20 CLIP signal was highly enriched at 
cap-proximal positions (Fig. 1E) and consistent with the individually examined pre-
mRNAs, ARS2, PHAX and ZC3H18 displayed more frequent cap-proximal reads 
than RBM7 or than that observed by the distribution of RNA-Seq reads, using either 
cytoplasmic poly(A)+ RNAs or rRNA-depleted total RNAs.  
To examine the maturation status of mRNAs bound by CBP20, ARS2, PHAX 
and ZC3H18, we next calculated the fraction of exon-intron (EI) or intron-exon (IE) 
junction reads in the respective libraries. Whereas RNA-Seq datasets contained 
mostly spliced reads, iCLIP with CBC and its binding partners recovered many 
unspliced transcripts, consistent with the nuclear localization of the proteins (Fig. 1F). 
CBP20 was most strongly enriched on spliced species, closely followed by PHAX, 
ARS2 and ZC3H18 (Fig. 1F). As expected, RBM7 exhibited a relatively stronger 
binding to IE junctions, consistent   with   its   accumulation   in   the   3’ ends of introns 
(Lubas et al., 2015).  
Taking these analyses together, we conclude that CBP20, ARS2, PHAX and 
ZC3H18 associate with both immature and mature mRNAs with a common 
preference for cap-proximal binding, consistent with previous biochemical 
experiments (Andersen et al., 2013; Hallais et al., 2013; Izaurralde et al., 1992; Ohno 
et al., 1987). RBM7, on the other hand, associates with RNA in a less cap proximal 
fashion. Hence, besides the surprising interaction of PHAX with pre-mRNA/mRNA, 
we note that the distinct ZC3H18 and RBM7 binding profiles suggest that a stable 
CBCN complex does not readily form within nuclear pre-mRNP/mRNP. 
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Targeting of ARS2, PHAX and ZC3H18 to different classes of RNAPII-derived 
transcripts 
To further characterize transcript association of the investigated factors, we first 
generated metagene profiles of read densities from individual libraries by anchoring 
sequence tags to pre-mRNA TSSs or TTSs. As expected from our previous 
analyses, this revealed sharp cap-proximal peaks of CBP20, ARS2, PHAX and 
ZC3H18, and a more moderate enrichment of RBM7 (Fig. 2A, red coloring). No major 
differences were observed for these proteins near the RNA   3’ends. Cap-proximal 
binding profiles for CBP20, ARS2, PHAX and ZC3H18 were also apparent for 
reverse transcribed PROMPTs (Fig. 2A, blue coloring), which became clearer when 
CLIP signals were   anchored   to   PROMPT   5’ends   (Fig.   2B)   as   defined   by   Cap 
Analysis of Gene Expression (CAGE) data (Andersson et al., 2014; Ntini et al., 
2013). As for pre-mRNAs, RBM7 bound PROMPTs with a more moderate cap-
proximal tendency. Interrogated proteins also accumulated close to the cap of long 
intergenic non-coding RNAs (lincRNAs; Fig. S3) and enhancer RNAs (eRNAs; Fig. 
2C), although the low-abundant nature of the latter in the utilized exosome-proficient 
cells only allowed a moderate spatial signal resolution. 
We next examined binding of factors to replication-dependent histone (RDH) 
RNAs, which are 3’end  processed by U7 snRNA and therefore not polyadenylated. 
All the investigated proteins bound to histone mRNAs, with PHAX and ZC3H18 
showing the highest fractions of CLIP reads (Fig. 2D). RDH genes also generate 
3’extended transcripts that may terminate at cryptic downstream polyadenylation (pA) 
sites (Gruber et al., 2012). Estimating iCLIP reads mapping to such 3’extensions  
relative to mature RDH transcript revealed elevated RBM7 binding compared to the 
other factors (Fig. 2D). A similar tendency was also observed when interrogating 
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independently transcribed sn(o)RNAs (Fig. 2E, inset). Primary snRNA transcripts are 
cleaved by the integrator complex to generate pre-snRNAs carrying extensions of 
less than 20 nucleotides ('short 3'extensions'), which are exported to the cytoplasm 
by CBC and PHAX to be processed into mature TMG capped snRNAs ((Matera et 
al., 2007) for review). SnRNA genes also produce transcripts carrying 3’extensions of 
a few hundred nucleotides (‘long 3’extensions’)   and whose degradation relies on 
ZC3H18 and NEXT (Andersen et al., 2013). Consistently, RBM7 binding was again 
elevated  on  long  3’extensions relative to mature RNAs (Fig. 2E, inset), but somewhat 
surprisingly this was not the case for ZC3H18 (see below). Finally, binding of factors 
to snoRNAs deriving from splicing of their host introns were analyzed, and revealed 
robust  RBM7  binding  to  mature  snoRNAs  and  their  3’extensions (Fig. 2F), consistent 
with NEXT-mediated decay from intronic 3’ends (Lubas et al., 2015). Interestingly, 
PHAX bound strongly to mature uncapped snoRNAs, whereas CBP20 and ARS2 did 
not, suggesting that PHAX may be recruited to these RNAs independently of 
CBC/ARS2.  
Taking the data together, we conclude that the CBC and its partners generally 
bind the same families of coding and non-coding capped RNAs. However, some 
differences can be observed. First, RBM7 contacts unprocessed,   long   3’extended  
snRNA and RDH transcripts, which most likely mirrors the NEXT-mediated activity of 
the RNA exosome on these species. Second, ARS2 and PHAX display a moderate 
enrichment on snRNAs as compared to e.g. CBP20, which is consistent with their 
role in snRNA export. This is however contrasted by their quantitatively robust 
binding to mRNA (Table S2). Such limited specificity of ARS2 and PHAX for snRNAs 
appears insufficient to faithfully identify these RNAs within the nucleus. 
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ARS2, PHAX and ZC3H18 display limited specificity within separate RNA families 
Although ARS2, PHAX and ZC3H18 bind families of capped RNA without strong 
selectivity, they might still bind different RNAs within one family. To address this 
question, we compared iCLIP read counts for individual transcripts between relevant 
libraries (Fig. 3A). This analysis revealed that all the bound mRNAs (conventional 
and RDH RNAs), lncRNAs and sn(o)RNAs displayed largely similar binding profiles 
for CBP20, ARS2, PHAX and ZC3H18. To try identify differently bound RNAs, we 
focused on PHAX and ZC3H18 that appeared to have the most diverse sets of 
targets (see Fig1B above). We performed a differential expression (DE)-Seq analysis 
of their respective iCLIP reads, which demonstrated that out of a total of 11,514 
RNAs, 79% were bound indistinguishably by the two proteins, while 7% and 14% 
were bound preferentially by ZC3H18 and PHAX, respectively (Fig. 3B). Most of the 
specific PHAX binding events occured on snRNAs, in agreement with previous 
analyses (Fig. 1B). We then focused on mRNAs and found that 74% of these targets 
were shared (Fig. 3C). Taken toghether, these analyses thus indicate that even 
within single RNA families, CBP20, ARS2, PHAX and ZC3H18 bind similar RNAs. 
This apparent lack of specificity was further confirmed by an analysis of the motifs 
enriched in the iCLIP reads: in agreement with binding primarily determined by cap 
proximity, no motifs were clearly identified other than CpG-rich streches, which are 
generally enriched near transcription start sites (data not shown). 
We next analyzed whether transcripts of different lengths would reveal any 
differential binding. To this end, all analyzed capped RNAs were ranked by their 
length and the cumulative distribution of reads was computed (Fig. 3D, left panel). 
This demonstrated a preference of PHAX and ARS2 for short RNAs, while RBM7 
bound preferentially longer transcripts in agreement with its enrichment on pre-
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mRNAs. We then tested whether this effect was driven by all RNA families and 
therefore repeated the calculation after removal of snRNAs (3D, middle panel), or 
both snRNAs and histone mRNAs (3D, right panel). This demonstrated that these 
two families were largely responsible for the preferential binding of PHAX to small 
RNAs, leaving only limited size discrimination for the remaining transcripts. 
Altogether, we conclude that CBP20, ARS2, PHAX and ZC3H18 bind similar 
transcripts at steady-state. For the large number of included mRNAs, we fail to detect 
any strong dependency on length for PHAX binding. 
 
Steady-state RNA binding of PHAX and ZC3H18 correlates poorly with function 
The surprise that PHAX and ZC3H18 bind similar RNAs despite having differently 
reported led us to ask whether the steady-state binding of these proteins correlated 
with transcript change upon factor depletion. Hence, we depleted PHAX or ZC3H18  
by RNAi in HeLa cells and profiled the resulting mRNA contents by RNA-Seq (Fig. 
3E). A DE-Seq analysis against a control siRNA revealed that 422 mRNAs were 
significantly affected by ZC3H18 depletion, while none were significantly affected by 
PHAX depletion, and this despite similar depletion efficiencies (Log2 ratios of -2.4 
and -1.7 for ZC3H18 and PHAX, respectively). This lack of effect of PHAX depletion 
on mRNAs was consistent with its known function as a pre-snRNA export factor but 
not with its iCLIP RNA binding profile, which displays robust mRNA binding.  
We then considered separately the mRNAs that were preferentially bound by 
PHAX or by ZC3H18 (see Fig. 3C). However, a similar fraction of mRNA was 
sensitive to the depletion of ZC3H18 regardless of their binding preference (Fig. 3E), 
and a similar percentage of mRNA sensitive to ZC3H18 depletion was also identified 
in the entire mRNA population (Fig. 3E). We conclude that the steady-state RNA 
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binding profiles of PHAX and ZC3H18 correlate poorly with protein function at the 
genome-wide level. 
 
ARS2 and ZC3H18 link the CBC to NEXT 
A way to rationalize that the interrogated factors largely share RNA targets, yet have 
different effect, would be that these proteins are part of the same complex. However, 
while previous analyses showed that the CBCA complex can interact with PHAX 
(forming CBCAP; (Hallais et al., 2013)), and with ZC3H18 and NEXT (forming CBCN; 
(Andersen et al., 2013)), no interactions have been reported between PHAX and 
ZC3H18/NEXT.  
Thus, to clarify these physical links further, we first determined protein-protein 
interactions between factors by performing pair-wise two-hybrid assays of the human 
proteins in yeast cells (Y2H). As expected, robust interactions were detected 
between RBM7 and ZCCHC8 as well as between ZC3H18 and ARS2 (Table I). 
Interactions of the CBC were monitored by co-expressing untagged CBP20 with 
CBP80 fused to the GAL4 DNA binding domain, together with the various preys 
fused to the GAL4 activation domain (Hallais et al., 2013). Using this strategy, we 
detected the expected interactions of the CBC with ARS2, PHAX and NELF-E, a 
protein previously shown to directly interact with the CBC and used as a positive 
control (Narita et al., 2007). Interestingly, a weak interaction was also detectable 
between the CBC and ZC3H18 (Table I). To gather more data, we used human, 
Drosophila and Arabidopsis ARS2 as well as human ZC3H18 as baits, and 
performed Y2H screens of cDNA libraries of matched species. This recapitulated the 
ARS2-ZC3H18 interaction with Drosophila factors and revealed two novel 
interactions: i) between the Arabidopsis homologs of ARS2 and PHAX; and ii) 
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between human ZC3H18 and ZCCHC8. The latter result was supported by the 
identification of a fragment located at the end of ZC3H18 (amino acids 746-953), 
which was sufficient to confer a robust interaction with ZCCHC8 in Y2H assays and 
co-IP experiments (Table I; Fig. S4A). The detected links of ARS2/ZC3H18 to the 
CBC, and of ZC3H18 to the NEXT component ZCCHC8 suggested a collective 
interpretation of the Y2H results as depicted in Fig. 4A. Consistent with previous 
affinity capture/mass spectrometry (AC/MS) and in vitro protein-protein interaction 
data (Andersen et al., 2013; Hallais et al., 2013; Lubas et al., 2011), the CBC and 
NEXT complexes constitute separate entities with no apparent direct interaction. 
Instead, contact between CBC and NEXT appears to be mediated by ZC3H18 and 
ARS2. Moreover, PHAX, like ZC3H18, is capable of interacting with the CBC and 
ARS2 (Fig. 4A, (Hallais et al., 2013)). 
To substantiate the Y2H interaction results, we conducted a RBM7-LAP co-IP 
experiment and interrogated the ability of this NEXT component to associate with 
CBC-related factors in the presence or absence of ARS2, PHAX or ZC3H18. 
Western blotting analysis of input samples from HeLa RBM7-LAP cells revealed that 
these three components were downregulated by administration of specific siRNAs, 
relative to control (CTRL) siRNAs (Fig. 4B, lanes 1-4). RBM7 efficiently co-IP’ed  
CBP80, ARS2, ZC3H18 and the NEXT component ZCCHC8, whereas PHAX was 
undetectable (Fig. 4B, lane 5). Consistently, depletion of PHAX did not change the 
RBM7 interaction pattern (Fig. 4B, lane 7). In contrast, depletion of either ARS2 or 
ZC3H18   significantly   decreased  RBM7’s   interaction  with  CBP80 (Fig. 4B, compare 
lanes 5, 6 and 8). Moreover, the ARS2-RBM7 association was lost upon ZC3H18 
depletion and the contact between RBM7 and ZC3H18 was moderately affected by 
ARS2 depletion. None of the RNAi experiments affected the ability of the RBM7-LAP 
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fusion to be captured by bead-bound GFP antibodies or its precipitation of the NEXT 
partner ZCCHC8. These results support the protein interactions suggested by the 
Y2H data and position ARS2 and ZC3H18 as critical factors bridging the CBC with 
the NEXT complex (Fig. 4B, right panel).  
The inability of RBM7 to IP PHAX (Fig. 4B), and the  absence  of  PHAX  in  IP’s  
of NEXT components and ZC3H18 (Andersen et al., 2013), suggested that the 
majority of cellular NEXT/ZC3H18 and PHAX might reside in separate protein 
assemblies. Consistent with this notion, a PHAX-3xFLAG AC/MS experiment 
efficiently detected ARS2, CBP80 and CBP20, but failed to detect ZC3H18, ZCCHC8 
and RBM7 (Fig. 4C, Table S3). Human MTR4 was detected in low, yet significant, 
yields, which likely reflects its interaction with the exosome, the core subunits of 
which were detected at similar quantities (Fig. 4D). 
 
PHAX and ZC3H18 compete for the CBC 
Given their mutual exclusive presence in IP eluates, we considered that PHAX and 
ZC3H18 might compete for binding to the CBC. To investigate this possibility, RBM7-
LAP interacting proteins were immobilized on GFP antibody-conjugated beads and 
challenged by increasing amounts of recombinant human PHAX produced in E. coli. 
In vitro, this recombinant protein was able to form a stable complex with the CBC 
(Fig. S4B). In control experiments without addition of exogenous protein or with 40 g 
of added BSA, RBM7-LAP was retained on beads with CBP20, CBP80, ARS2, 
ZC3H18 and hMTR4 (Fig. 5A, left panel lanes 4 and 6). In contrast, addition of PHAX 
caused CBP20, CBP80 and ARS2 to be dissociated in a concentration-dependent 
manner, whereas ZC3H18, and hMTR4 remained bead-bound with RBM7-LAP (Fig. 
5A, left panel lanes 5-12). Thus, exogenous PHAX was capable of breaking the link 
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between ZC3H18/NEXT and the CBC (Fig. 5A, right panel), suggesting a competition 
between PHAX and ZC3H18 for binding the CBC. 
Further support for this idea was obtained by employing the Lumier assay, 
which yields a quantitative measure of the in vivo interaction between two proteins of 
interest (Fig. 5B, left panel). A construct harboring CBP20 fused at its N-terminus to 
the Firefly Luciferase (FFL) protein and 3xFLAG (3xFLAG-FFL-CBP20) was 
transfected into HEK293T cells together with a construct expressing either PHAX 
(RL-PHAX) or ZC3H18 (RL-ZC3H18) N-terminally fused to the Renilla Luciferase 
protein. Subsequently, whole cell extracts were subjected to anti-FLAG IPs and 
luciferase activities were measured in both the input extracts and their IP pellets. As 
a measure of interaction specificity, RL was first plotted as fold enrichment over 
control beads with no FLAG antibody, confirming that both RL-PHAX and RL-
ZC3H18 exhibited robust interaction with 3xFLAG-FFL-CBP20 (Fig. 5B, right panel). 
These interactions were then challenged by overexpression of putative competitor 
proteins (Fig. S4C). Consistent with the proposed CBCN architecture (Fig. 4A), 
overexpression of NEXT components had no effect on the ZC3H18-CBP20 
interaction (Fig. 5C, right panel). A similar result was obtained employing hnRNPC, 
another proposed CBC binder (McCloskey et al., 2012). However, in agreement with 
the in vitro experiments of Fig. 5A, overexpression of PHAX readily displaced 
ZC3H18 from CBP20. ARS2 overexpression also decreased the interaction, possibly 
by titrating ZC3H18 from a CBC/ARS2/ZC3H18 ternary assembly. Challenging the 
PHAX-CBP20 interaction in a similar manner revealed that overexpression of NEXT 
components and hnRNPC again had no effects (Fig. 5D), whereas overexpression of 
ZC3H18 diminished the PHAX-CBC20 contact. Overexpression of ARS2 also 
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displaced PHAX from CBP20, which again could be due to a titration of PHAX from 
the CBC-ARS2-PHAX complex. 
Based on all of our data, we suggest that NEXT contacts the CBC through 
Z3CH18 and ARS2, and that the formation of CBC-ARS2-PHAX and CBC-ARS2-
ZC3H18 is mutually exclusive. 
 
PHAX and ZC3H18 have opposite effects on RNA levels 
Whereas our CLIP data showed that ZC3H18 and PHAX associate with the same set 
of RNAs, our biochemical experiments demonstrated that these factors cannot 
simultaneously bind the CBCA complex. This suggests that an RNA bound by CBCA 
may transition between complexes containing either ZC3H18 or PHAX. If these 
proteins elicit different functional outcomes, RNA fate might then be dictated by 
which RNP complex is favored at the time this  ‘decision’  has  to  be  taken. To address 
the validity of this hypothesis, we first employed a tethering assay to explore the 
functional consequences of binding PHAX or ZC3H18 to an RNA reporter. Hence, we 
fused ZC3H18 or PHAX to the MS2 coat protein (MCP), which itself was fused to 
GFP (MCP-GFP-X), and co-expressed one of these fusion-proteins together with a 
plasmid expressing an RL RNA reporter carrying two MS2 binding sites in its 3'-UTR 
as well as a FFL control RNA to adjust for transfection efficiencies (Fig. 6A). 
Tethering of ZC3H18 decreased RL expression, which was likely due to recruitment 
of the NEXT complex, since tethering of the ZC3H18746-953 fragment, sufficient for 
ZCCHC8-interaction (Table 1; Fig. S4A), had a similar effect (Fig. 6B, left panel). In 
stark contrast, tethering of PHAX induced a robust increase in RL activity. These 
effects were also reflected at the level of RL RNA (Fig. 6B, right panel).  
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To test the effects of PHAX and ZC3H18 on endogenous RNAs, we turned to 
snRNAs,  whose  long  3’extended  species  are  known  to  be degraded by the exosome 
in an ZC3H18/NEXT dependent manner (Andersen et al., 2013), providing useful 
model substrates. As expected, depleting ZC3H18 generally increased levels of 
3’extended RNAs derived from eight different snRNA genes and the capped U3 
snoRNA gene (Fig. 6C; see depletion efficacy in Fig. S5). In contrast, levels of the 
same substrates generally decreased upon PHAX depletion, whereas co-depletion of 
PHAX and ZC3H18 cancelled the effects of the individual depletions, which was also 
evident when averaging all snRNA substrates (Fig. 6C,   ‘All  snRNAs’). Interestingly, 
the effect of co-depletion was not always simply the addition of the individual 
depletion effects. For instance, depletion of ZC3H18 had little effect on U1.1 
3'extended transcripts. Still, it completely cancelled the negative effect of depleting 
PHAX, suggesting that ZC3H18 had gained access to these RNAs in the absence of 
PHAX. Thus, the absence of one protein sensitized transcripts to the presence of the 
other. This is in line with a model where ZC3H18 and PHAX compete for RNA bound 
by CBCA to yield opposite functional outcomes.  
 
PHAX and ZC3H18 exchange rapidly on the CBC in vivo 
The idea that CBCA-bound RNPs might transition between CBCA-PHAX and CBCA-
ZC3H18 forms implies that PHAX and ZC3H18 do not simply bind and ‘mark’  RNPs  
for different destinies. It also implies that PHAX and ZC3H18 rapidly exchange on 
and off the CBC. To test this prediction, we employed a LacO/Laci co-recruitment 
assay (Hallais et al., 2013), to measure the lifetime of these interactions in living 
U2OS cells. We tethered CBP20 to an array of genomic LacO sites, by fusing it to a 
red fluorescent version of the Laci protein (mRFP-Laci-CBP20). Transfected cells 
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displayed a diffuse nuclear mRFP-Laci-CBP20 signal in addition to a concentrated 
bright spot, corresponding to the location of the LacO array ((Hallais et al., 2013); 
Fig. S6A). We next tested whether the mRFP-Laci-CBP20 'spot’ would recruit its 
various partners. Indeed, co-transfected GFP-tagged versions of CBP80, ARS2, 
PHAX and ZC3H18 concentrated in mRFP-Laci-CBP20 spots (Fig. S6A, left and right 
panels). This recruitment was specific as the proteins were not enriched in a control 
spot formed by mRFP-Laci-KPNA3 (Fig. S6B). We could also demonstrate that 
ARS2, PHAX and ZC3H18 interactions were dependent on RNA as a mutant form of 
CBP20 that does not bind the cap (F83A F85A; (Mazza et al., 2001)), failed to recruit 
these proteins, and yet did not prevent CBP80 interaction as expected (Fig. S6C). In 
agreement with these results, we detected polyA+ RNA accumulating in the mRFP-
Laci-CBP20 spot (Fig. S7C). 
Having established a functional experimental design, we employed 
‘fluorescent   recovery   after   photobleaching’ (FRAP) to measure the dynamics of 
mRFP-Laci-CBP20 interactions with its GFP-tagged partners. After photobleaching 
the LacO spot, the mRFP-Laci-CBP20 fluorescence showed very slow recovery over 
a two minutes time-course, indicating stable binding of the fusion protein to the LacO 
array (Fig. 7A, right panel). GFP-CBP80 recovered quickly when photobleached in 
the nucleoplasm, but only slowly (within minutes) in the mRFP-Laci-CBP20 spot, 
consistent with a stable interaction between these CBC subunits in vivo. In contrast, 
ARS2 and PHAX recovered quickly when photobleached in the Laci-CBP20 spot, 
with half-times of recovery of only a few seconds (Fig. 7B and 7C). Still, these 
kinetics were slower than recovery in the nucleoplasm, suggesting that dissociation 
of ARS2 and PHAX from the CBC is slower than the time it takes these molecules to 
diffuse through the bleached spot. Because ZC3H18 interacted with itself in the co-
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recruitment assay (Fig. S6D), we performed the FRAP assay by tethering mRFP-
Laci-ZC3H18 to the LacO array. This ensured that the photobleaching of GFP-
CBP80 only measured the interaction between this protein and tethered ZC3H18 
(see Experimental Procedures). This revealed a rapid (within seconds) recovery of 
the GFP-CBP80 signal to the spot formed by mRFP-Laci-ZC3H18 (Fig. 7D).  
Modeling of the FRAP data showed that the lifetime of the CBP20-CBP80 
interaction was in the order of minutes, whereas the lifetime of CBP20 interactions 
with ARS2, PHAX or ZC3H18 was much shorter and in the range of 3-13 seconds 
(Table S4). 
 
 
Discussion 
Eukaryotic cells produce various types of RNA that each follow a certain 
processing/decay and/or transport pathway. How proper transcript sorting into 
appropriate pathways occurs is a fundamental but incompletely understood problem. 
As the CBC promotes the processing of different RNAs, yielding family-specific 
effects (Gonatopoulos-Pournatzis and Cowling, 2014; Müller-McNicoll and 
Neugebauer 2014), it provides an interesting model to study the concept of RNA 
sorting. It has been suggested that such family- or transcript-specificity derives from 
CBC partners binding only certain RNAs, hereby acting as identity marks (Ohno et 
al., 2002). Our results do not support this idea, but instead suggest an alternative 
model where early RNP complexes are constantly remodeled, and determine RNA 
fate by reacting to external input at specific times during RNA biogenesis. 
 
Binding of some landmark RNA binding proteins (RBPs) is promiscuous and not 
sufficient to define RNA maturation pathways 
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Early studies in Xenopus oocytes demonstrated that distinct RNA families use non-
overlapping nuclear export pathways (Jarmolowski et al., 1994). Consistently, it was 
found that pre-snRNAs and mRNAs use distinct exportins and export adaptors: 
PHAX/CRM1 for pre-snRNAs (Ohno et al., 2000), and TAP, in association with 
ALYREF or other RBPs, for mRNAs (Björk and Wieslander, 2014; Grüter et al., 1998; 
Segref et al., 1997). Such specificity for a given export pathway appeared to stem 
from specific binding of key RBPs, such as PHAX or the EJC, to pre-snRNAs and 
spliced mRNAs, respectively (Ohno et al., 2002). This further suggested the 
possibility that RNA identity could be determined early on in the nucleus, perhaps 
even during transcription, and then stably maintained due to specific RNA-coating by 
certain RBPs. The iCLIP data presented here do not support this hypothesis. This is 
because we detect binding of PHAX not only to pre-snRNAs as expected, but also to 
a large range of other capped RNAs, including PROMPTs, eRNAs, lincRNAs, RDH 
RNAs and polyadenylated mRNAs. In fact, the fraction of total PHAX iCLIP reads 
mapping to mRNA approaches 40%, and is not restricted to particular mRNA 
species; not even to short transcripts as would perhaps have been predicted. When 
compared to CBP20, which expectedly binds to all capped RNAs, PHAX exhibits 
some preference for pre-snRNAs, but this specificity is moderate. With the notable 
exception of intronic snoRNAs, it is also important to note that binding of PHAX to 
RNA is likely to occur mainly through the CBC, which can be appreciated by the 
largely cap-proximal binding of the protein (see Fig. 1E and Fig. 2). The limited target 
specificity of PHAX is thus probably not due to promiscuous RNA binding, but rather 
to its loading onto RNA via cap-bound CBC. Binding of even a key RBP like PHAX is 
therefore poorly discriminating. It may even be argued that PHAX is a bona fide 
mRNA binding protein and that it could have a previously unnoticed role in mRNA 
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biogenesis. However, PHAX depletion revealed little effect on steady-state mRNA 
levels or splicing patterns in transcriptome-wide experiments . Furthermore, steady-
state binding of PHAX and ZC3H18, as determined by iCLIP, correlated poorly with 
effects on RNA levels upon depletion of these proteins (see Fig. 3E). Using PHAX 
and ZC3H18 as a paradigm, we therefore suggest that binding specificity per se may 
generally not be sufficient to identify RNAs and determine their fate. A notable 
exception may be the EJC, which binds stably to spliced RNA and thus provides a 
more definitive identity mark (Le Hir et al., 2000a; Le Hir et al., 2000b). However, the 
EJC is deposited as a result of splicing, and it is thus a stable label for a transient 
phenomenon, much like the polyA tail is for 3'end processing. 
 
Mutually exclusive formation of CBC complexes at specific maturation checkpoints 
may determine RNA fate 
Live cell imaging of RBPs has demonstrated their transient interaction with RNA, 
allowing rapid sampling of sequences (Phair and Misteli, 2000). In agreement, our 
FRAP data show that CBC-containing complexes are quite labile, with a half-life of 
only a few seconds. With RNAPII elongation rates of about 2 kb/min (Boireau et al., 
2007; Jonkers et al., 2014), a medium-sized human gene takes 50 min to 
transcribe. Splicing and mRNA export also takes minutes (Audibert et al., 2002; 
Beyer and Osheim, 1988; Schmidt et al., 2011). This suggests that PHAX and 
ZC3H18 continuously exchange at the CBC-bound cap during RNA production. 
Thus, instead of using steady-state binding as a mechanism to identify RNAs and 
control their fate, many RBPs, including PHAX and ZC3H18, might be part of a 'hit-
and-run' mechanism, where transcript fate would originate from ‘locking’  of  decisive  
complexes only at particular checkpoints during pre-mRNA processing. The ability of 
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RNPs to form mutually exclusive complexes with proteins having opposing activities 
may reflect the need of the RNP to keep all options open until one outcome would 
have to be selected out of several possibilities. Indeed, it may simply reflect the fact 
that  RNAPII   ‘does  not  know’  which   type  of   transcription  unit   it is engaged with until 
relevant cues are instigated. 
We suggest that one such cue, or checkpoint, may occur when a 3'end 
processing signal emerges from the RNAPII exit channel. Processing signals drive 
the assembly of specific proteins, which may then synergize with the CBC to lock the 
proper complex and produce the required outcome. In support of this model, CBCA 
was shown to stimulate the usage of a range of 3'end processing signals (Hallais et 
al., 2013). Moreover, NEXT complex components purify with 3'end processing factors 
(Shi et al., 2009). Thus, a cryptic, cap-proximal 3'end/termination signal might 
promote an interaction between the CBCA complex at the RNA 5'end with NEXT at 
the 3'end, via ZC3H18. This would stabilize the CBCN complex, which would serve to 
exclude PHAX while simultanuously increase the access of NEXT and the exosome 
to the RNA 3'end. Example substrates for such a scenario would be PROMPTs, 
whose early termination and degradation rely on promoter proximal polyA sites as 
well as the CBCA, NEXT and exosome complexes (Andersen et al., 2013; Ntini et al., 
2013). In contrast, the 3'end processing signal of an snRNA would recruit the 
Integrator complex (Baillat et al., 2005), which might bias the competition between 
PHAX and ZC3H18 toward the formation of the CBCAP complex (Hallais et al., 
2013), excluding ZC3H18/NEXT and resulting in productive 3'end formation. If proper 
3’end   formation   is   missed,   as   e.g.   in   the   case   of   ‘long   3’extended’   sn(o)RNAs,  
downstream cryptic termination sites might again favor CBCN formation and 
transcript decay. 
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In this study, we have focused on RNA transport via PHAX and RNA decay 
via ZC3H18/NEXT. Because the CBC has many activities, it is however likely that 
dynamic exchanges of mutually exclusive protein complexes at RNA caps may also 
interplay with other processing events, such as for instance RNA splicing. We 
propose that the constant remodeling of CBC-associated complexes allows the 
dynamic integration of a diverse source of signals, whereas a pre-determined, rigid 
CBC complex, deposited for instance at the start of transcription, would not allow 
such regulation. 
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Experimental Procedures 
Cell culture 
HeLa, U20S and HEK293 cells   were   grown   in   Dulbecco’s modified eagle medium 
(DMEM) containing 10% fetal bovine serum (FBS) and 1% Penicilin/Streptavidin, at 
37°C, 5% CO2. For iCLIP experiments, epitope-tagged proteins were expressed in 
two cell systems: (i) HEK293 Flp-In T-Rex cells stably expressing C-terminally 
3XFLAG–tagged ZC3H18 under control of a tetracycline-inducible promoter or (ii) 
HeLa Kyoto cells stably expressing LAP-tagged proteins (ARS2, CBP20, PHAX) from 
integrated BACs (Poser et al., 2008). The expression of 3xFLAG-ZC3H18 was 
induced by replacing cell growth media with fresh media containing Tetracycline. For 
the RNA IP and manual CLIP experiment, 3x-Flag-ARS2 and 3x-Flag-PHAX were 
stably expressed in HeLa cells from clones generated by Flp-In recombination 
(Hallais et al., 2013). 
 
Plasmids 
DNA cloning was performed using standard techniques and the Gateway™ system 
(InVitrogen). The two-hybrid plasmids were based on pACTII, p422 and pAS2dd 
(Hallais et al., 2013). For the LUMIER competition assay, the bait and prey were 
expressed on non-replicative plasmids (without the origin of replication of SV40), 
while the competitor was on a replicative plasmid (pcDNA3.1). The competitors were 
N-terminally fused to a myc tag. The cDNAs were all of human origin except for 
PHAX which was a mouse cDNA. For the MS2 tethering experiments, the reporter 
plasmid was based on PSICHECK-2. For the LacO tethering assay, the proteins of 
interest were expressed from the mouse L30 promoter, as C-terminal fusions with 
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GFP or mRFP-Laci (Hallais et al., 2013). Detailled maps and sequences are 
available upon requests. 
 
siRNAs and RNA-Seq analysis 
The utilized siRNAs had the following sequences: 5' 
CAACAAGCAUGCAGAGAAAdTdT (siARS2); 5' CUUACGCUGAGUACUUCGAdTdT 
(siControl against firefly luciferase); 5' UAAAUCCUGUGCUAUAUACUCdTdT 
(siPHAX); 5' GGAAUGAAUUGUAGGUUUAdTdT (siZC3H18). For the RNA-Seq 
experiments, the PHAX siRNAs were 5′-UAGUAUCAGCGAGGAACAAAUUA dT 
dT and 5′-AAGAGUAUAUAGCACAGGAUUUA dT dT. For the LUMIER assays, the  
control siRNA was 5' CAACAGAAGGAGAGCGAAA dT dT. 
 Cells were transfected for 3 days using Lipofectamin2000 (20 l/ml in the 
transfection mixture, together with 0.4 M of siRNA), and with at a final siRNA 
concentration of 20 nM in the cell culture medium. For RNA-Seq experiments, HeLa 
cells were transfected with PHAX, ZC3H18 or control siRNAs using JetPrime 
(PolyPlus), and cells were harvested 48h later. RNAs from triplicate experiments 
were prepared using TRIzol (Thermo Fisher), and rRNA were removed using the 
RiboMinus kit (Thermo Fisher). RNAs were sequenced using paired-end sequencing, 
mapped against the human genome, and analyzed using the DE-Seq package in R. 
Raw sequence data are available in GEO (accession number XXXXX). 
 
Antibodies 
Antibodies were from the following sources, and used for western blotting analysis at 
the indicated dilutions. Anti-ARS2: Abcam (Ab88392; 1:1000); anti-GFP: Santa Cruz 
(sc-9996; 1:250); anti-hMTR4: Abcam (Ab70551; 1:2500); anti-RBM7: Sigma-Aldrich 
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(HPA013993); anti-ZCCHC8: Abcam (Ab8739; 1:500; anti-ZC3H18: Sigma-Aldrich 
(HPA040847; 1:500). Anti-CBP20 and CBP80 were gifts from E. Izaurralde and were 
used at 1:1000 and 1:10000, respecively. Anti-PHAX was a mouse monoclonal 
antibody (Hallais et al., 2013), and used at 1:500. 
 
iCLIP 
The iCLIP approach was performed as described in (Konig et al., 2011) with the 
additional modifications of (Lubas et al., 2015), which include differences in 
sonication and washing buffers. All iCLIP experiments were performed in two 
biological replicates. Briefly, cells were crosslinked with 300 mJ/cm2 at 254nm UV. 
Upon cell lysis, RNAs were partially fragmented using low concentrations of RNase I, 
and protein-RNA complexes were IP’ed with antibodies (single chain GFP-Trap 
nanobodies for LAP-tagged cells and -FLAG M2 antibodies for 3×FLAG-ZC3H18 
cells) coupled to magnetic beads (Dynabeads M-270 Epoxy, Life Technologies). 
Beads were washed three times in 50 mM Tris/HCl, pH 8.0, 150 mM NaCl 0.5% (v/v) 
TritonX100. An additional step of on-beads RNase I treatment was performed, and 
beads were washed again in 50 mM Tris/HCl, pH 8.0, 2000 mM NaCl, 0.5% (v/v) 
TritonX100, 2M Urea for GFP-tagged proteins, or 50 mM Tris/HCl, pH 8.0, 1000 mM 
NaCl, 0.5% (v/v) TritonX100, 1M Urea for 3xFLAG-ZC3H18 CLIPRNAs were then 
radioactively labelled, subjected to denaturing gel electrophoresis and transferred to 
a nitrocellulose membrane, to remove RNAs that were not covalently linked to 
proteins. RNAs were recovered from membranes by proteinase K digestion and 
reverse transcribed. cDNA molecules were size-purified using denaturing gel 
electrophoresis, PCR-amplified and subjected to high-throughput sequencing.  
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Bioinformatics analysis of iCLIP data 
High-throughput sequencing of iCLIP cDNA libraries from two replicate experiments, 
of each interrogated factor, was performed by Illumina HiSeq 2000 sequencing. 
Sequenced   reads   were   trimmed   of   the   fixed   3’adaptor   and   filtered   by   quality   and  
insert length using Flexbar (http://sourceforge.net/projects/flexbar/). The reads were 
collapsed and demultiplexed based on their 5' adaptor sequences, which contained a 
4-nt experiment-specific barcode for sample multiplexing and a random 5 nt region to 
control for PCR artefacts. Reads were mapped to the hg19 human genome assembly 
using TopHat (Trapnell et al., 2009) with a known splice junction database (-GTF 
option) from iGenomes (http://support.illumina.com 
/sequencing/sequencing_software/igenome.ilmn). Reads mapping to the same 
position with the same counting barcode were collapsed, and reads mapping to 
multiple independent genomic locations were assigned randomly to one of these 
locations, whereas reads mapping across splice junctions were assigned to both 
sides of the junction. Genomic annotations were assigned based on gene 
annotations from the UCSC genome browser and from published datasets 
(Andersson et al., 2014; Cabili et al., 2011; Derrien et al., 2012; Kishore et al., 213; 
Ntini et al., 2013). 
Bedtools (Quinlan and Hall, 2010) were used for analyses of read coverage in 
genomic feature. For calculation of coverage piecharts, reads were uniquely 
assigned to RNA biotypes using a hierarchical procedure, starting with the most 
abundant biotypes. For metagene analyses of coverage around mRNA TSSs and 
TTSs, we used a filtered subset of 5,769 well-annotated Refseq mRNAs that 
contained no known rRNA, tRNA, miRNA or sn(o)RNA in the mRNA introns or within 
2 kb of the transcript boundaries. 
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To compare the CLIP data with total RNA abundances, we used 
representative RNA-Seq datasets downloaded from the Sequence Read Archive 
(http://www.ncbi.nlm.nih.gov/sra). We used cytoplasmic poly(A)+-selected data from 
HeLa (SRR3479116; (Lykke-Andersen et al., 2014)) and HEK293 (SRR1275413), as 
well as rRNA-depleted total RNA from HeLa (SRR1014903) and HEK293  cells 
(SRR2096982). It is worth noting that all commonly used protocols for RNA-Seq 
library preparations have specific biases regarding the length and modification status 
of RNAs, so that discrepancies between RNA-Seq and iCLIP profiles are expected. 
RNA-Seq data were analyzed with the same pipeline as iCLIP, except for the 
demultiplexing step based on the random barcode information, which was only used 
for iCLIP. 
 
RNA IP and CLIP validation assays 
For the IPs of Fig. S2A-S2C, cells were rinsed in PBS, scraped and lysed for 30 min 
at 4°C in IP buffer (50mM Tris-HCl pH 7.4, 150mM NaCl, 1mM EDTA, 1mM MgCl2, 
15% glycerol, 1% NP40, anti-protease cocktail from Roche). Cellular debris was 
removed by centrifugation (10 min at 9000g), and extracts were incubated with 
antibody-coated beads (2 to 4 h at 4°C). Beads were then washed five times in IP 
buffer and resuspended in TRIzol (Invitrogen). The antibodies used were monoclonal 
-PHAX antibodies (clones 10E3 and 17E11; (Hallais et al., 2013)) and a monoclonal 
-FLAG (M2, Sigma), coupled to protein G sepharose (4 fast flow; GE Healthcare).  
For the manual iCLIP experiments of Fig. S2D, cells were UV-crosslinked on 
ice, using two irradiations of 700 J each. Cells were then lyzed in RBS500 buffer 
(10mM Tris-Hcl, pH 7.5, 500 mM NaCl, 2.5 mM MgCl2, 0.5% Triton, 1% Empigen-
BB, anti-protease cocktail). Empigen-BB is a charged detergent. Extracts were 
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incubated 3h at 4°C with beads coated with M2 -FLAG antibody. Subsequently 
beads were washed 5 times in RBS500, and resuspended in TRIzol (Invitrogen) to 
extract RNAs. Controls were constituted by the same amount of extract of HeLa cells 
not expressing 3XFLAG-PHAX. 
 
RNase protection and RT-qPCR assays 
RNA  was  purified  using  TRIzol  according  to  the  manufacturer’s   instructions.  RNAse 
protection assays were performed with the RNAPIII kit (Ambion), using 32P labeled 
probes spanning the 3'end of HIST1H4B or RPS28 mRNAs. The RPS28 probe also 
contained an oligodT stretch to specifically detect polyadenylated RPS28 mRNA.  
For RT-qPCR analysis, RNAs were treated with DNase RQ1 (Sigma) for 1 h 
at 37°C to digest residual genomic DNA. Reverse transcription (RT) was performed 
using the SuperScript II RT enzyme (Invitrogen) and N6 random priming oligos. 
qPCR was performed using SYBR Green PCR Master Mix (Roche) or a previously 
described SYBER Green mix (Lutfalla and Uze, 2006). RT-qPCR reaction were 
normalized to the mean of the values obtained with 18S  and 28S amplicons. The 
oligo used were the following. Primer_U1.1_F: 5' TTACCTGGCAGGGGAGATAC; 
Primer_U1.1_R: 5' GCAGTCGAGTTTCCCACATT; U1.1 -RT _F: 5' 
GTGAAGTCCGCTCAGCTCTT; U1.1 -RT _R: 5' TGGAAGCAGAGGCTGTGTAA; 
U2.1-F: 5' ATCCGAGGACAATATATTAAATGGA; U2.1-R: 5' 
CGTTCCTGGAGGTACTGCAA; U2.1 -RT _F: 5' CCTTGAGGTTCCTGATGTGC; 
U2.1 -RT _R: 5' ATCCTAAGGACCTCCCCAAA; U4.2-F: 5' 
GCAGTATCGTAGCCAATGAGG; U4.2-R: 5' TGCCAATGCCGACTATATTT; U4.2 -
RT_F: 5' GCAGGTTGTGTCTTATGTTTGG; U4.2 -RT_R: 5' 
AGAACCCCGGACATTCAATC; 18S-F: 5' TGCCCTATCAACTTTCGATG; 18S-R: 
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5'CTTGGATGTGGTAGCCGTTT; 28S-F: 5' GGGTATAGGGGCGAAAGACT; 28S-R: 
5' CGCTTTACCGGATAAAACTGC 
 
AC/MS and IP analyses 
For AC/MS analysis, we used HEK293 Flp-In T-Rex cells stably expressing C-
terminally 3XFLAG-tagged PHAX under control of a tetracycline-inducible promoter. 
Cryogenic disruption of cells and 3XFLAG-AC methodology were performed as 
previously described  (Andersen et al., 2013; Domanski et al., 2012).  
AC was performed in extraction buffer consisting of 150 mM NaCl, 0.5% Triton 
X-100, 20mM HEPES pH7.4 and supplemented with protease inhibitor. Experiments 
were performed label-free and in triplicates. Prior to AC, cell extracts were treated 
with 100μg/ml RNase A. Elution of bait-captured proteins was performed by mixing in 
50μl of 0.5M Acetic Acid for 10 min at RT. Collected eluates were neutralized with 5μl 
of 5.5M Ammonium Hydroxide. Samples were concentrated to 30μl and processed 
using the FASP protocol (Wiśniewski et al., 2009). Trypsinized samples were 
acidified with 0.1% TFA, desalted using C18 stage tips and analyzed by MS using an 
LTQ Orbitrap Velos instrument (Thermo Scientific). Data acquisition, processing and 
plotting were performed as described (Hubner and Mann, 2011). The full dataset is 
accessible in the Table S3. 
IP experiments were performed essentially as described (Domanski et al., 
2012). For the PHAX competition assay, CBCN assembly was first immobilized on 
the magnetic beads by co-IP of RBM7-LAP (as above). Next, the beads were divided 
into 5 tubes, resuspended in 10 μl of the extraction buffer only, extraction buffer 
containing BSA (40 μg) and extraction buffer containing increasing amount of PHAX 
(10-40 μg). Samples were incubated for 20 min at RT with mixing (1100 rpm, 
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thermomixer). After collecting the supernatant (S) beads were washed once with the 
extraction buffer and remaining protein material was eluted (E) with 1x LDS protein 
loading buffer. Proteins were separated by SDS-PAGE followed by transfer onto 
PVDF membrane. To avoid unspecific signal, the membrane was blocked in 5% 
skimmed milk / PBS-T for 1 hour at RT. Next, the membrane was cut into pieces for 
incubation with the following antibodies: anti-ZC3H18, -ARS2, -hMTR4, -CBP80, -
CBP20 and -GFP. Incubation with the primary and HRP-conjugated secondary 
antibodies (both in 5% skimmed milk / PBS-T) was performed for 1 hour at RT. The 
membrane was washed in between 3 x 5 min with PBS-T. After incubation with the 
ECL substrate, chemiluminescence was detected using X-Ray film.  
For the co-IP combined with RNAi, HeLa RBM7-LAP cells were seeded on 
150 mm dishes at  ~5x10^6 cells in 20 ml of DMEM, transfected with siRNA, and 
processed after three days as indicated above.  
 
Production of recombinant full-length human PHAX 
The human PHAX full-length sequence 1-384 was cloned into pETM11 vector 
containing a TEV cleavable six-histidine tag. Expression in E. coli Rosseta 2 cells 
was induced with 0.4 mM IPTG and performed for 6h at 25°C. Cells were 
resuspended in 300 mM NaCl, 50 mM HEPES pH 7.8, 10% (v/v) glycerol, 5 mM β-
mercaptoethanol and lysed by sonication. Soluble protein was captured after 
centrifugation (1h, 10°, 35 000 g) by immobilized metal ion affinity chromatography 
(Chelating Sepharose Fast Flow, GE Healthcare) and eluted after several washes 
with 300 mM imidazol. After TEV cleavage and dialysis (100 mM NaCl, 20 mM 
HEPES 7.8, 10 mM β-mercaptoethanol) the protein was further purified by ion 
exchange chromatography and heparin column (HiPrep Heparin HP, GE Healthcare). 
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After concentrating (Amicon® Ultra Centrifugal filters, MERCK Millipore) the protein 
was analyzed by size exclusion chromatography (S200, GE Healthcare). 
 
Yeast two-hybrid assay 
Yeast two-hybrid and bridged two-hybrid assays were performed as previously 
described (Boulon et al., 2008). For bridged assays, pACT-II and p422 (ADE2 
multicopy) plasmids were introduced into Y187 strains, while pAS2ΔΔ plasmids were 
transformed into CG1945 strain. Strains were crossed and diploids were plated on 
triple and quadruple selective media (−Leu −Trp −Ade or −Leu −Trp −Ade −His). 
Growth was assessed visually after 3 days at 30°C. A similar protocol was used for 
regular two-hybrid assays, except that p422 plasmids and adenine selection were 
omitted. 
 
LUMIER assays 
HEK293T cells were grown and transfected on 6-well plates. Two days after 
transfection, cells were extracted in 450 l HNTG with anti-protease coktail and 
RNase A (60 g/ml), at 4°C for 15 minutes. Cellular debris were removed by 
centrifugating at 20 000g for 5 minutes. Antibody coated beads were incubated with 
180 l of extracts for 2h at 4°C, and beads were washed three times in HNTG. Beads 
were resuspended in PBL buffer (Promega), and luciferase activity were measured in 
the IP and pellets using the dual-luciferase assay (Promega). HNTG is 20 mM 
HEPES, pH 7.9, 150 mM NaCl, 1% Triton, 10% glycerol, 1 mM MgCl2, 1 mM EGTA, 
and protease inhibitors (Roche). 
 
MS2 Tethering assay 
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HEK293 cells were cotransfected with the luciferase reporter plasmid containing two 
MS2 stem-loops in its 3' UTR and with plasmids expressing MCP-GFP fused to the 
protein of interest. Two days later, cells were lysed in PBL buffer (Promega) and 
firefly and renilla luciferase activities were measured using the dual luciferase kit as 
recommended by the manufacturer (Promega). 
 
Microscopy and LacO FRAP assay 
U2OS cells carrying a LacO array (Marzec et al., 2015) were plated on coverslips 
and co-transfected using JetPrime (PolyPlus) with plasmids expressing the GFP 
fusion of interest together with the mRFP-Laci fusion of interest. Two days later, cells 
were  either fixed and visualized by wide-field microscopy, or imaged live using a 
Zeiss Lsm780 microscope. FRAP was performed on a spot with a radius of 1.5 m 
using 10 iterations at full laser power, and images were collected every 96 ms. The 
mean fluorescence intensities of a bleached and of a non-bleached area were 
calculated for each time point (Ispot and Icell). The background signal was measured 
outside the cell (Ibkg). The bleaching and background corrected fluorescence intensity 
was then calculated at each time point I = (Ispot-Ibkg) / (Icell-Ibkg). This value was then 
normalized  to 1 by dividing it with the value of I computed with the averaged pre-
bleach time points.  
CBP20 was tethered to the LacO array while its partners were expressed as 
soluble GFP fusions, exept for ZC3H18. Indeed, ZC3H18 interacts with itself and by 
tethering CBP20 to LacO and expressing GFP-ZC3H18, complexes of the following 
type could form: LacO-CBP20-ZC3H18-ZC3H18-CBP20-LacO. In such complexes, 
ZC3H18 could dissociate from CBP20 and nevertheless could remain attached to the 
array by virtue of its interaction with the second molecule of ZC3H18. This difficulty is 
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avoided if ZC3H18 is tethered to LacO, because the soluble GFP-CBC complex can 
only make a single  interaction with ZC3H18. 
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Table I. Two-hybrid interactions between CBC-related proteins 
 
 ARS21 PHAX ZC3H18 RBM7 ZCCHC8 NELF-E Alix2 
ARS21 nd - ** - - - - 
PHAX - nd - - - - - 
RBM7 - - - nd ** - - 
ZCCHC8 na na na na na na na 
CBC3 ** ** * - - ** - 
ZC3H18 ** - nd - - - - 
ZC3H18 
(746-953)4 - nd - nd ** nd - 
ARS2 
screen5 
nf nf nf nf nf nf nf 
dARS2 
screen5 
nf nf 7 (380-
639) 
nf nf nf nf 
atARS2 
screen5 
nf 1 (18-
154) 
nf nf nf nf nf 
ZC3H18 
screen5 
nf nf nf nf 1 (265-
694) 
nf nf 
 
1Colomns and rows indicate the relevant cDNA fused to the GAL4 activation- and DNA-binding 
domains, respectively. Interaction strength is indicated by the number of stars. nd: not done; na: not 
applicable due to constitutive activation of the reporter; nf: not found in the library screen. -: no 
interaction. 
2Human protein used as a negative control. 
3CBC subunits were co-expressed in yeast cells. CBP80 was fused to the GAL4 DNA-binding domain 
and CBP20 was non-tagged. 
4In this row, ZC3H18746-953 was tested against the indicated preys except for ZCCHC8, for which the 
fragment used was ZCCHC8265-694. This is the ZCCHC8 fragment found in the ZC3H18 Y2H screen. 
5Screens were performed with the full-length proteins fused to the DNA-binding domain of LexA. 
Numbers before parentheses denote how many independent clones were found. Numbers within 
parentheses denote the smallest interacting fragment of the prey (in amino acids). 
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Figure Legends 
Figure 1. Cap-proximal mRNA binding by ARS2, PHAX and ZC3H18 
A. Schematic overview of the different protein complexes relevant for this study. 
CBCAP is shown in yellow, NEXT in purple, and CBCN is circled in green. See text 
for details. 
B. Fractions of iCLIP reads, from replicate libraries, mapping to the indicated classes 
of capped or uncapped RNA expressed as proportions of total library reads. Reads 
marked as "others" could not be unambiguously assigned to any of the above 
categories. For comparison, we show cytoplasmic poly(A)+-selected RNA-Seq data 
from HEK293 cells (SRR1275413) and HeLa cells (SRR3479116), as well as RNA-
Seq data from rRNA-depleted total RNA from HEK293 cells (SRR2096982) and 
HeLa cells (SRR1014903). 
C, D. Genome browser views of representative protein-coding genes PPIA (B) and 
RPS16 (C), showing iCLIP reads from replicate CBP20, ARS2, PHAX, ZC3H18 and 
RBM7 samples. Reads mapping to the PPIA and RPS16 RNAs are shown as 
mapped Reads Per Million (RPM) library reads (see scale bar to the right of the 
image). Purple color implies that displayed reads exceed the used scale. 
E. Fractions of iCLIP or RNA-Seq reads mapping within cap-proximal regions of 100, 
500 or 1000 nts of 5,769 well-annotated pre-mRNA genes. The iCLIP results 
represent averages of replicate experiments. 
F. Fractions of exon-intron (EI) and intron-exon (IE) junction reads, averaged 
between replicate experiments, mapping over Refseq pre-mRNAs. Fractions were 
calculated as EI/(EI+IE+EE) and IE/(EI+IE+EE) as indicated. EE: exon-exon junction 
reads. Note that EI- are higher than IE-fractions for CBP20 libraries in agreement 
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with the cap-binding nature of this protein. Conversely, IE- are higher than EI-
fractions for RBM7 libraries as previously reported (Lubas et al., 2015). 
 
Figure 2. ARS2, PHAX and ZC3H18 are targeted to common RNA families 
A. Density profiles of reads from the indicated iCLIP libraries displayed as Reads Per 
Million (RPM) library reads, around -/+2kb regions of transcription start sites (TSSs, 
left part) and Transcript Termination Sites (TTSs, right part) of the protein-coding 
genes from Fig. 1D. Transcription directions are indicated by arrows as forward 
(’mRNA   direction’)   and   reverse   (’PROMPT  direction’). Red and blue reads map to 
forward and reverse strands, respectively. Signal corresponding to 1 RPM is 
indicated. Note that CBP20 and ZC3H18 mRNA profiles were disrupted to ease 
visual inspection.  
B. Density profiles as in (A) but only showing reverse read densities in -/+2kb regions 
anchored around PROMPT TSSs as defined by CAGE summits (Chen et al., 2016). 
Signal corresponding to 1 RPM is indicated. 
C. Density profiles as in (A) but showing forward and reverse read densities in -/+2kb 
regions anchored around eRNA TSSs as defined by CAGE summits (Chen et al., 
2016). Signal corresponding to 0.05 RPM is indicated. 
D. Proportion of reads from the indicated replicate libraries mapping to mature (white 
columns)  and  3’extended  regions  (light  green  columns)  of  RDH  RNAs.  ‘3’ extensions’  
denote 1-500   nt   downstream   of   the   annotated   mature   RDH   RNA   3’end. Note 
disruption of the y-axis to ease visual inspection of all data. 
E. Proportion of reads mapping to mature (white columns), short- (light green) and 
long- (dark  green)  3’extended  regions  of  independently  transcribed  sn(o)RNAs.  ‘short  
3’extensions’  and   ‘long  3’extensions’ denote 1-20 nts and 50-500 nts, respectively, 
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downstream of the annotated mature sn(o)RNA   3’ends. Inset shows the ratio of 
reads  mapping  to  long  3’extensions  relative  to  mature  RNA. 
F.   Proportion   of   reads   mapping   to   5’extended- (blue columns), mature- (white 
columns)   and   3’extension- (light green columns) regions of uncapped snoRNAs 
located in introns.  5’- and  3’-extension  denote   regions   from   the  mature  snoRNA  5’- 
and  3’-ends to the  respective  intronic  5’- and  3’-ends, respectively. 
 
Figure 3. ARS2, PHAX and ZC3H18 are targeted to common transcripts  
A. Scatter plots showing RPKM values of iCLIP-tags from one indicated library 
versus another. Each RNA species is a dot. Grey: pre-mRNAs; violet: histone 
mRNAs; light blue: lncRNAs; red: sn(o)RNAs. 
B. Scatter plot showing the log2 fold changes in PHAX vs. ZC3H18 binding, as a 
function of normalized read counts for all RNAs identified in the iCLIP experiments. 
RNAs binding similarly to PHAX and ZC3H18 (grey dots) or significantly more to one 
protein (red dots) were determined by the DE-Seq package. 
C. Venn diagram displaying mRNAs bound by PHAX (yellow) and/or ZC3H18 
(green), as determined by DE-Seq analysis of the iCLIP data. 
D. Cumulative distribution of iCLIP reads from the indicated replicate libraries ranked 
as a function of RNA size (x-axis). Left: all capped RNAs; middle: all capped RNAs 
except snRNAs; right: all capped RNAs except snRNAs and histone mRNAs. 
E. Bar plots displaying fractions of mRNA affected by ZC3H18 depletion (red) in the 
entire mRNA population (left) or in the mRNAs preferentially bound by PHAX or 
ZC3H18 (middle and left, respectively). The mean change in expression levels upon 
depletion of ZC3H18 is shown in blue, for the same RNA population. PHAX- and 
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ZC3H18-bound mRNAs are shown in Fig. 3C. The differences between the three 
populations are not statistically significant. 
 
Figure 4. Molecular organization of CBC-related complexes 
A. Schematic overview of Y2H data acquired from pair-wise tests and cDNA library 
screens (see Table I). The interaction of hMTR4 and the core exosome with 
RBM7/ZCCHC8   is   indicated.   ‘Previously  demonstrated  direct physical interaction’ is 
from (Andersen et al., 2013; Hallais et al., 2013; Lubas et al., 2011; Ohno et al., 
2000). 
B. Left panel: Western blotting analysis of RBM7-LAP co-IP experiments conducted 
from extracts of HeLa cells depleted of factors using siRNAs as indicated. ‘CTRL’  
denotes control siRNA targeting firefly luciferase mRNA. Input samples used for IP 
are shown to the left (lanes 1-4) and eluate samples from the IP are shown to the 
right (lanes 5-8). Schematics to the right depict the interpretation of the conducted 
co-IPs.  
C. Volcano plot displaying the result of triplicate PHAX-3XFLAG AC/MS experiments. 
The log2 fold change of peptide MS intensities between bait and reference ('bait-less' 
cell line) eluate samples (x-axis) were plotted against the negative log10 p-values (y-
axis) calculated across the triplicate data (t-test). A dashed red curve separates 
specific PHAX-interacting proteins (upper right part of plot) from enriched proteins 
from the reference cell line (upper left part of plot). Some PHAX-interacting protein 
groups are color-coded as indicated in legend, and protein names relevant for this 
study are denoted. The full data set of specific co-precipitants is given in Table S3. 
D. Column chart displaying abundance of selected proteins from PHAX-3XFLAG AC 
eluates. Peptide intensities divided by protein MW were normalized to results for the 
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bait protein. In this analysis, reference values were not subtracted from bait values as 
the reference procedure yielded more background material binding to unshielded 
antibody epitopes sometimes obscuring analysis (data not shown). Note disruptions 
of the y-axis to reveal intensities of all plotted factors. 
 
Figure 5. PHAX and ZC3H18 make mutually exclusive interactions with the CBC 
in vitro and in vivo 
A. Left panel: Western blotting analysis of RBM7-LAP co-IP experiments challenged 
with increasing amounts of exogenously added PHAX (lanes 7-12) or BSA (40 g) 
(lanes 5 and 6) as a negative control. CTRL denotes that no exogenous protein was 
added. PHAX or BSA was added to bead-bound RBM7-LAP complexes. IN: Input; 
FT: flow-through; S: bead supernatant upon addition of the indicated protein; E: SDS-
eluate of the materials left on the beads following addition of the indicated protein. 
Antibodies used for the analysis are shown to the left. Right panel: Schematic 
interpretation of the experimental result. 
B. LUMIER assay showing interaction of 3xFLAG-FFL-CBP20 with RL-PHAX and 
RL-ZC3H18. Left panel: Schematic representation of the assay. Right Panel: Graph 
depicting efficiency of RL-PHAX and RL-ZC3H18 interactions with 3xFLAG-FFL-
CBP20. Values are enrichment fold of RL-ZC3H18/RL-PHAX in the FLAG IP over a 
control IP performed with empty beads. Extracts were prepared from HEK293T cells 
transiently transfected with the corresponding plasmids. 
C. LUMIER assay testing effect of overexpression of MYC-tagged competitor 
proteins on RL-ZC3H18 binding to 3x-FLAG-FFL-CBP20. Left: schematic of the 
assay. Right: graph depicting efficiency of RL-ZC3H18 interaction with 3xFLAG-FFL-
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CBP20. Values are enrichment fold of RL-ZC3H18 (IP/Input), normalized by the 
3xFLAG-FFL-CBP20 values (IP/Input).  
D. LUMIER assay as in (C) but testing the effect of overexpression of MYC-tagged 
competitor proteins on RL-PHAX binding to 3x-FLAG-FFL-CBP20. 
 
Figure 6. PHAX and ZC3H18 exhibit antagonistic effects on RNA levels 
A. Schematic representation of the employed tethering assay. An RL reporter RNA 
containing two MS2 binding sites in its 3'UTRs was contained on a plasmid also 
harboring an FL reporter to control for transfection efficiencies. This plasmid was co-
transfected with a plasmid expressing candidate polypeptides fused to MS2-GFP 
(MCP-GFP-X) or with a plasmid expressing MS2-GFP alone. 
B. Effects on RL reporter activity of tethering MCP-GFP-X fusions. Left panel: 
RL/FFL activity ratios obtained with the MCP-GFP-X fusion, and normalized to the 
same ratio derived from the corresponding MCP-GFP control sample. Right panel: 
RL/FFL RNA ratios measured by RT-qPCR and expressed as Log2 fold ratios 
between the MCP-GFP-X protein and the control MCP-GFP fusion. Bars represent 
standard deviations from >5 experiments. 
C. Effects of PHAX and ZC3H18 single- and double-depletions on levels of snRNA 
species carrying long 3’extension. Levels of the indicated transcripts were measured 
by RT-qPCR on RNA extracted from HeLa cells treated with the indicated siRNAs 
(color-coded as displayed on the right). Values are displayed as Log2 fold changes 
relative to samples treated with a control FFL siRNA. Bars represent standard 
deviations from >3 independent transfection experiments. Stars indicate 
significatively different values (p<0.02 with a t-test).  
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Figure 7. PHAX, ARS2 and ZC3H18 exchange rapidly on the CBC in vivo 
A-C. Two left panels: confocal images of U2OS cells carrying a LacO array and co-
transfected with plasmids expressing the indicated proteins (fields of view are 30x30 
microns; left: GFP; right: mRFP). Middle rectangular panels: confocal images of a 
FRAP experiment of the GFP-tagged protein (fields of view are 10x48 microns). 
Right panels: fluorescent recovery curves of the indicated proteins. The FRAP 
experiments in the green and red channels were performed independently. Dark 
green: The indicated GFP-tagged protein in the nucleoplasm; light green: The 
indicated tagged protein in the LacO spot; red: the mRFP-Laci-CBP20 fusion in the 
LacO spot. Y-axes denote fluorescence intensities corrected for photobleaching and 
normalized to pre-bleach intensities. X-axes denote time in seconds. Grey bars 
represent standard deviations calculated from >10 different cells. 
D. As in A-C, except that ZC3H18 was fused to Laci and tethered to the LacO spot in 
place of CBP20. 
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